These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30006163)

  • 1. Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery.
    Foley DW; Pathak RB; Phillips TR; Wilson GL; Bailey PD; Pieri M; Senan A; Meredith D
    Eur J Med Chem; 2018 Aug; 156():180-189. PubMed ID: 30006163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy.
    Du Y; Tian C; Wang M; Huang D; Wei W; Liu Y; Li L; Sun B; Kou L; Kan Q; Liu K; Luo C; Sun J; He Z
    Drug Deliv; 2018 Nov; 25(1):1403-1413. PubMed ID: 29890854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro transport of model thiodipeptide prodrugs designed to target the intestinal oligopeptide transporter, PepT1.
    Foley D; Pieri M; Pettecrew R; Price R; Miles S; Lam HK; Bailey P; Meredith D
    Org Biomol Chem; 2009 Sep; 7(18):3652-6. PubMed ID: 19707666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
    Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
    Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
    Anand BS; Patel J; Mitra AK
    J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir.
    Gourdon B; Chemin C; Moreau A; Arnauld T; Baumy P; Cisternino S; Péan JM; Declèves X
    Int J Pharm; 2017 Aug; 529(1-2):357-370. PubMed ID: 28705621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of levovirin prodrugs in the human intestinal Caco-2 cell line.
    Li F; Hong L; Mau CI; Chan R; Hendricks T; Dvorak C; Yee C; Harris J; Alfredson T
    J Pharm Sci; 2006 Jun; 95(6):1318-25. PubMed ID: 16634069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
    Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
    Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport.
    Gourdon B; Chemin C; Moreau A; Arnauld T; Delbos JM; Péan JM; Declèves X
    Eur J Pharm Biopharm; 2018 Aug; 129():122-133. PubMed ID: 29803721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivatable Pseudotripeptidization of Cyclic Dipeptides To Increase the Affinity toward Oligopeptide Transporter 1 for Enhanced Oral Absorption: An Application to Cyclo(l-Hyp-l-Ser) (JBP485).
    Jiang Q; Zhang J; Tong P; Gao Y; Lv Y; Wang C; Luo M; Sun M; Wang J; Feng Y; Cao L; Wang G; Wang Y; Kan Q; Zhang T; Wang Y; Liu K; Sun J; He Z
    J Med Chem; 2019 Sep; 62(17):7708-7721. PubMed ID: 31393124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
    Cao F; Gao Y; Wang M; Fang L; Ping Q
    Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrug design targeting intestinal PepT1 for improved oral absorption: design and performance.
    Zhang Y; Sun J; Sun Y; Wang Y; He Z
    Curr Drug Metab; 2013 Jul; 14(6):675-87. PubMed ID: 23869811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ketone drugs towards transport by the intestinal peptide transporter, PepT1.
    Foley D; Bailey P; Pieri M; Meredith D
    Org Biomol Chem; 2009 Mar; 7(6):1064-7. PubMed ID: 19262922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability, metabolism and transport of D-Asp(OBzl)-Ala--a model prodrug with affinity for the oligopeptide transporter.
    Steffansen B; Lepist EI; Taub ME; Larsen BD; Frokjaer S; Lennernäs H
    Eur J Pharm Sci; 1999 Apr; 8(1):67-73. PubMed ID: 10072480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine.
    Tamai I; Nakanishi T; Hayashi K; Terao T; Sai Y; Shiraga T; Miyamoto K; Takeda E; Higashida H; Tsuji A
    J Pharm Pharmacol; 1997 Aug; 49(8):796-801. PubMed ID: 9379359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1.
    Pak YA; Long AJ; Annes WF; Witcher JW; Knadler MP; Ayan-Oshodi MA; Mitchell MI; Leese P; Hillgren KM
    Drug Metab Dispos; 2017 Feb; 45(2):137-144. PubMed ID: 27895114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.
    Nielsen CU; Andersen R; Brodin B; Frokjaer S; Taub ME; Steffansen B
    J Control Release; 2001 Sep; 76(1-2):129-38. PubMed ID: 11532319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.
    Friedrichsen GM; Chen W; Begtrup M; Lee CP; Smith PL; Borchardt RT
    Eur J Pharm Sci; 2002 Jul; 16(1-2):1-13. PubMed ID: 12113886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.